Assyro AI

FDA PDUFA dates in September 2026

Published PDUFA target action dates for NDAs, BLAs, ANDAs, and INDs scheduled in September 2026, sourced from FDA primary records.

Tracking 11 published FDA PDUFA decisions, including 8 NDAs and 3 BLAs.

FDA PDUFA dates in September 2026: 11 published FDA PDUFA target action dates. Select a row to expand its full record.
SponsorProductTypeApplicationPDUFA dateStatusExpand and copy
AdvicenneSibnayalNDAPENDING-provisional|advicenne|sibnayal|distalrenaltubulaupcoming
Telix PharmaceuticalsTLX101-Px (Pixclara)NDAPENDING-provisional|telixpharmaceuticals|tlx101pxpixclarupcoming
NuvalentzidesamtinibNDAPENDING-provisional|nuvalent|zidesamtinib|ros1positivenoupcoming
Ultragenyx PharmaceuticalUX111BLAPENDING-provisional|ultragenyxpharmaceutical|ux111|sanfiupcoming
MerckWINREVAIRBLAPENDING-provisional|merck|winrevair|pulmonaryarterialhypupcoming
Ionis PharmaceuticalszilganersenNDAPENDING-provisional|ionispharmaceuticals|zilganersen|aleupcoming
Incyte Corporation / Mirum PharmaceuticalsZilurgisertibNDAPENDING-provisional|incytecorporationmirumpharmaceuticalupcoming
Praxis Precision MedicinesrelutrigineNDAPENDING-provisional|praxisprecisionmedicines|relutrigineupcoming
BiofronteraAmeluz-PDTNDAPENDING-provisional|biofrontera|ameluzpdt|superficialbasupcoming
Egetis TherapeuticsEmcitate (tiratricol)NDAPENDING-provisional|egetistherapeutics|emcitatetiratricoupcoming
Scholar RockapitegromabBLAPENDING-provisional|scholarrock|apitegromab|spinalmusculupcoming

Select any row to expand its full record. Use the calendar, timeline, status board, or table views above to filter, sort, and inspect source-linked details.

September 2026 FDA PDUFA Calendar: Drug Approval Dates & Deadlines

Track September 2026 FDA PDUFA dates for NDA, BLA, ANDA, and IND decisions. Free drug approval tracker with source-linked deadlines, calendar views, and daily updates.